Skip to Main Content

Author Details

Alexander D Borowsky
University of California Davis Health
1995
179
50
PMIDPaper TitleJournal TitlePublished Year
37226827A Pilot Validation Study Comparing Fluorescence-Imitating Brightfield Imaging, A Slide-Free Imaging Method, With Standard Formalin-Fixed, Paraffin-Embedded Hematoxylin-Eosin-Stained Tissue Section Histology for Primary Surgical Pathology Diagnosis.Arch Pathol Lab Med2024
37226827A Pilot Validation Study Comparing Fluorescence-Imitating Brightfield Imaging, A Slide-Free Imaging Method, With Standard Formalin-Fixed, Paraffin-Embedded Hematoxylin-Eosin-Stained Tissue Section Histology for Primary Surgical Pathology Diagnosis.Arch Pathol Lab Med2024
36683225Chronic Exposure to Low Levels of Parabens Increases Mammary Cancer Growth and Metastasis in Mice.Endocrinology2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37592077Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.Nat Rev Endocrinol2023
37398016Combined near infrared photoacoustic imaging and ultrasound detects vulnerable atherosclerotic plaque.medRxiv2023
37330193Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease.Neurosci Lett2023
37190318Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA.Cancers (Basel)2023
36683225Chronic Exposure to Low Levels of Parabens Increases Mammary Cancer Growth and Metastasis in Mice.Endocrinology2023
37592077Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.Nat Rev Endocrinol2023
37674811Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma.JTO Clin Res Rep2023
37190318Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA.Cancers (Basel)2023
37398016Combined near infrared photoacoustic imaging and ultrasound detects vulnerable atherosclerotic plaque.medRxiv2023
37330193Biochemical analyses of tau and other neuronal markers in the submandibular gland and frontal cortex across stages of Alzheimer disease.Neurosci Lett2023
35078042In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.Biomaterials2022
35847493Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop <i>via</i> NRF2 in cancer therapeutic resistance.Acta Pharm Sin B2022
35504287Gene regulatory networks shape developmental plasticity of root cell types under water extremes in rice.Dev Cell2022
35424752Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent.RSC Adv2022
35863345Mapping hormone-regulated cell-cell interaction networks in the human breast at single-cell resolution.Cell Syst2022
36253270A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangement.Clin Lung Cancer2022
35976643Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy.Arch Pathol Lab Med2022
36970720Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.Cancer Res Commun2022
35332139Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis.NPJ Breast Cancer2022
35027560The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer2022
35205085Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation.Biology (Basel)2022
35078042In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.Biomaterials2022
35847493Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop <i>via</i> NRF2 in cancer therapeutic resistance.Acta Pharm Sin B2022
35504287Gene regulatory networks shape developmental plasticity of root cell types under water extremes in rice.Dev Cell2022
35424752Magnetic resonance imaging of tumor-associated-macrophages (TAMs) with a nanoparticle contrast agent.RSC Adv2022
36970720Identifying Good Candidates for Active Surveillance of Ductal Carcinoma <i>In Situ</i>: Insights from a Large Neoadjuvant Endocrine Therapy Cohort.Cancer Res Commun2022
35863345Mapping hormone-regulated cell-cell interaction networks in the human breast at single-cell resolution.Cell Syst2022
36253270A Common Cell of Origin for Inflammatory Myofibroblastic Tumor and Lung Adenocarcinoma with ALK rearrangement.Clin Lung Cancer2022
35976643Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy.Arch Pathol Lab Med2022
35332139Intratumoral in vivo staging of breast cancer by multi-tracer PET and advanced analysis.NPJ Breast Cancer2022
35205085Use of RNA-Seq and a Transgenic Mouse Model to Identify Genes Which May Contribute to Mutant p53-Driven Prostate Cancer Initiation.Biology (Basel)2022
35027560The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ.NPJ Breast Cancer2022
33441763Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.Sci Rep2021
34010619Innovation, conservation, and repurposing of gene function in root cell type development.Cell2021
33763068Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.Front Immunol2021
33441763Immune modulation resulting from MR-guided high intensity focused ultrasound in a model of murine breast cancer.Sci Rep2021
34344894Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry.NPJ Breast Cancer2021
34131071HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.Mol Cancer Res2021
34491200Vision, challenges and opportunities for a Plant Cell Atlas.Elife2021
34534466Innovation, conservation, and repurposing of gene function in root cell type development.Cell2021
34529196The WISDOM study: a new approach to screening can and should be tested.Breast Cancer Res Treat2021
33763068Targeting the Aryl Hydrocarbon Receptor Signaling Pathway in Breast Cancer Development.Front Immunol2021
34529196The WISDOM study: a new approach to screening can and should be tested.Breast Cancer Res Treat2021
34491200Vision, challenges and opportunities for a Plant Cell Atlas.Elife2021
34534466Innovation, conservation, and repurposing of gene function in root cell type development.Cell2021
34131071HER2 Isoforms Uniquely Program Intratumor Heterogeneity and Predetermine Breast Cancer Trajectories During the Occult Tumorigenic Phase.Mol Cancer Res2021
  • 1 - 50 of 358

Recommended Authors

Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 1
University of California los angeles
Career Start Year 2003
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2002
Number of shared co-authors 3
Virginia Commonwealth University
Career Start Year 2002
Number of shared co-authors 0
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2002
Number of shared co-authors 0
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Huntsman Cancer Institute, University of Utah
Career Start Year 1999
Number of shared co-authors 6
Western University
Career Start Year 1999
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 2
European Cancer Stem Cell Research Institute, Cardiff University
Career Start Year 1998
Number of shared co-authors 6
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1997
Number of shared co-authors 3
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Baylor College of Medicine
Career Start Year 1996
Number of shared co-authors 5
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 3
University Health Network
Career Start Year 1994
Number of shared co-authors 0
Cancer Research UK Cambridge Institute
Career Start Year 1994
Number of shared co-authors 6
Georgetown University
Career Start Year 1993
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1992
Number of shared co-authors 3
Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1991
Number of shared co-authors 7
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 6
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 10
University of Utah
Career Start Year 1986
Number of shared co-authors 3
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
University of California
Career Start Year 1984
Number of shared co-authors 5
Queen's University
Career Start Year 1982
Number of shared co-authors 3
Wellcome Sanger Institute
Career Start Year 1980
Number of shared co-authors 8
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1978
Number of shared co-authors 5
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 2

Collaborators

University of California San Francisco
Co-authored papers 5
Co-authored papers 4
University of California Davis Davis
Co-authored papers 4
Oregon Health & Science University Hospital.
Co-authored papers 4
University of California San Francisco
Co-authored papers 4
University of California irvine
Co-authored papers 3
University of California Davis
Co-authored papers 3
Co-authored papers 3
Institute for Human Genetics, University of California San Francisco (UCSF)
Co-authored papers 3
University of California davis
Co-authored papers 2
National Cancer Institute
Co-authored papers 2
University of California San Diego
Co-authored papers 2
Oregon Health and Science University
Co-authored papers 2
University of California davis
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California
Co-authored papers 2
Duke University School of Medicine
Co-authored papers 2
University of California davis
Co-authored papers 2
university of california san diego
Co-authored papers 2
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 2
Institute for Genomic Medicine, University of California San Diego
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 2
Co-authored papers 2
University of California San Francisco
Co-authored papers 2
Buck Institute for Research on Aging
Co-authored papers 2
Department of Medicine and Moores Cancer Center, University of California San Diego.
Co-authored papers 2
Stanford University School of Medicine
Co-authored papers 2